Antabio SAS
EIC Accelerator Winner From 2022
A novel combination treatment effective against all multidrug-resistant pathogens deemed as a critical priority by the WHO
France
Articles
Antabio SAS: Advancements and Funding Highlights Post-EIC Accelerator 2022
FranceEIC Accelerator2022
Read Article